BioLineRx Ltd.
Price Action
Technical Summary
CONSOLIDATINGBioLineRx Ltd. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 72), indicating performance broadly in line with the market. Earnings contraction of 10% provides fundamental context to the price action. Investors should exercise caution due to high volatility (63% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.25 | -4.74% | BELOW |
| 50 SMA | $3.03 | +2.38% | ABOVE |
| 100 SMA | $2.83 | +9.64% | ABOVE |
| 150 SMA | $2.91 | +6.51% | ABOVE |
| 200 SMA | $3.11 | -0.40% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BLRX in an uptrend right now?
BLRX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is BLRX overbought or oversold?
BLRX's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is BLRX outperforming the market?
BLRX has a Relative Strength (RS) Rating of 72 out of 99. BLRX is performing about average compared to the market.
Where is BLRX in its 52-week range?
BLRX is trading at $3.10, which is 61% of its 52-week high ($5.06) and 32% above its 52-week low ($2.18).
How volatile is BLRX?
BLRX has a Beta of 0.79 and 52-week volatility of 63%. It's less volatile than the S&P 500 - generally more stable.